SLC22A12 and hyperuricemia: The results indicated that MOL-FP accelerated the excretion of UA and effectively reduced the serum UA level in hyperuricemia mice by up-regulating the expression of ABCG2 and down-regulating the expression of URAT1 and GLUT9.